.

Senior appointments to strenghten health science research

Prof Andrew Pitt and Dr Corinne Spickett join Aston
Prof Andrew Pitt and Dr Corinne Spickett join Aston

4th Febuary 2010

Aston University has appointed two new senior positions within its School of Life and Health Sciences.

Professor Andrew Pitt has joined Aston in the newly created post of Chair of Pharmaceutical Chemistry and Chemical Biology within Aston Pharmacy School.

Dr Corinne Spickett joins Aston as Reader in Biochemistry to further augment the Institution's growing reputation in the translation of analytical science to biomedicine.

Professor Andrew Pitt; Andrew was formerly the Scientific Director of the RASOR consortium, Director of the Sir Henry Wellcome Functional Genomics Facility and the Doctoral Training Centre in Proteomic Technologies, and a Reader at the University of Glasgow. He has a strong track record in interdisciplinary research, exploiting the interfaces between chemistry, biology, engineering and medicine. His study areas include generating new technologies and techniques for studying biological systems from cells to living organisms, leading to an understanding of how dysfunction leads to disease and developing new treatments to overcome these. This includes the use of chemistry, physics and biology to study protein function, creating a ‘molecular nose’ to sense the complex responses of cells to external stimulation or internal damage, and identifying biological markers that will give insights into disease. Professor Pitt’s research at Aston will continue the development of these areas, as well as expanding his research on the use of chemical methods to study and alter biological systems.

 Dr Corinne Spickett; Corinne joins Aston’s Life and Health Sciences team from a senior lectureship at the Strathclyde Institute of Pharmacy and Biomedical Sciences. Her research focuses in particular on oxidative stress within the body. This includes the damaging effects of free radicals and oxidants on cells and tissues where they are clearly implicated in the pathology of the disease, such as in cardiovascular disease (CVD) and the underlying condition atherosclerosis. Dr Spickett will be continuing to increase and foster her international collaborative research at Aston with projects including a COST Action CM1001 on Chemistry of non-enzymatic protein modification and a Euro MEMBRANES project on oxidized phospholipids. She will also be involving in setting up a state-of-the-art mass spectrometry facility in Life and Health Sciences, and will participate in Aston Research Centre for Healthy Ageing (ARCHA).

 -ends

For further press information please contact Alex Earnshaw, University Communications on 0121 204 4549

 

 



Employable Graduates; Exploitable Research